Breast cancer metastasis through the lympho-vascular system

Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, p...

Full description

Saved in:
Bibliographic Details
Published inClinical & experimental metastasis Vol. 35; no. 5-6; pp. 443 - 454
Main Authors Nathanson, S. David, Krag, David, Kuerer, Henry M., Newman, Lisa A., Brown, Markus, Kerjaschki, Dontscho, Pereira, Ethel R., Padera, Timothy P.
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.08.2018
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon.
AbstractList Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon.
Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon.Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon.
Author Brown, Markus
Pereira, Ethel R.
Kerjaschki, Dontscho
Kuerer, Henry M.
Nathanson, S. David
Krag, David
Newman, Lisa A.
Padera, Timothy P.
Author_xml – sequence: 1
  givenname: S. David
  surname: Nathanson
  fullname: Nathanson, S. David
  email: dnathan1@hfhs.org
  organization: Department of Surgery, Division of Surgical Oncology, Henry Ford Cancer Institute
– sequence: 2
  givenname: David
  surname: Krag
  fullname: Krag, David
  organization: College of Medicine, University of Vermont
– sequence: 3
  givenname: Henry M.
  surname: Kuerer
  fullname: Kuerer, Henry M.
  organization: Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center
– sequence: 4
  givenname: Lisa A.
  surname: Newman
  fullname: Newman, Lisa A.
  organization: International Center for the Study of Breast Cancer Subtypes, Henry Ford Health System
– sequence: 5
  givenname: Markus
  surname: Brown
  fullname: Brown, Markus
  organization: Genentech
– sequence: 6
  givenname: Dontscho
  surname: Kerjaschki
  fullname: Kerjaschki, Dontscho
  organization: Department of Pathology, Medical University of Vienna
– sequence: 7
  givenname: Ethel R.
  surname: Pereira
  fullname: Pereira, Ethel R.
  organization: Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, MGH and Harvard Medical School
– sequence: 8
  givenname: Timothy P.
  surname: Padera
  fullname: Padera, Timothy P.
  organization: Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, MGH and Harvard Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29796854$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtLxDAUhYMoOqP-ADdScOMmepM2TYIrFV8guNF1SNPE6dDHmKTC_HtTRhEGdHU58J3D4Z452u2H3iJ0QuCCAPDLQIAJhoEILCVQTHbQjDCeY055uYtmQEuKQUhxgOYhLAGg4FzsowMquSwFK2bo6sZbHWJmdG-szzobk9KhCVlc-GF8X6Rrs3bdrRYD_tTBjK32WViHaLsjtOd0G-zx9z1Eb_d3r7eP-Pnl4en2-hmbnNOI80paYJxoI12VOwN1CVqIJHVdVMK5qiCyKsGBraWwgta1yFlNidM5J-DyQ3S-yV354WO0IaquCca2re7tMAZFoWC0lFSyhJ5tocth9H1qN1GJAEpIok6_qbHqbK1Wvum0X6uftySAbwDjhxC8dco0Ucdm6KPXTasIqGkAtRlApQHUNICaosmW8yf8Pw_deEJi-3frf0v_bfoCOkqW_g
CitedBy_id crossref_primary_10_1007_s00259_023_06496_7
crossref_primary_10_1155_2021_2234554
crossref_primary_10_1007_s12032_024_02477_4
crossref_primary_10_1007_s10549_023_07084_x
crossref_primary_10_3390_medicina57111272
crossref_primary_10_1186_s12957_024_03306_8
crossref_primary_10_3390_ijms232012141
crossref_primary_10_1016_j_compbiomed_2021_104571
crossref_primary_10_1186_s12957_023_03273_6
crossref_primary_10_3389_fonc_2020_566511
crossref_primary_10_3389_fonc_2022_967655
crossref_primary_10_4236_jct_2024_159031
crossref_primary_10_1038_s41598_019_52746_w
crossref_primary_10_1186_s12885_024_13001_2
crossref_primary_10_3390_cancers13020211
crossref_primary_10_1021_acsnano_2c02314
crossref_primary_10_1051_e3sconf_202130802022
crossref_primary_10_3389_fonc_2020_608334
crossref_primary_10_3389_fonc_2021_715097
crossref_primary_10_1007_s10585_018_9920_z
crossref_primary_10_3390_cells11081263
crossref_primary_10_2174_2211738510666220304111848
crossref_primary_10_1007_s10585_024_10288_0
crossref_primary_10_3389_fonc_2020_571100
crossref_primary_10_3390_ijms19103047
crossref_primary_10_1155_2022_4066179
crossref_primary_10_3390_diagnostics12010004
crossref_primary_10_1016_j_pharmthera_2022_108108
crossref_primary_10_2174_1568009619666190718124541
crossref_primary_10_3390_ijms23010103
crossref_primary_10_3389_fgene_2022_1009056
crossref_primary_10_1007_s00432_024_05907_y
Cites_doi 10.1001/jamaoncol.2017.0595
10.1016/S1470-2045(10)70207-2
10.1093/jnci/djv048
10.1038/nrc3677
10.1001/jamasurg.2014.1086
10.1245/s10434-017-5958-4
10.1002/cncr.25066
10.1002/cam4.998
10.1002/cncr.25862
10.1001/jama.295.21.2492
10.1245/s10434-017-5977-1
10.1200/JCO.2015.64.0094
10.1097/SLA.0000000000001863
10.1186/s13058-016-0684-6
10.1038/bjc.2013.650
10.1200/JCO.2013.54.1177
10.1001/jama.2013.278932
10.1200/JCO.2015.62.2126
10.1016/S1470-2045(13)70035-4
10.1111/j.1365-2559.2010.03568.x
10.1245/s10434-009-0659-2
10.1007/s10549-014-2899-5
10.1001/jamasurg.2017.0005
10.1200/JCO.1998.16.8.2672
10.1200/JCO.2015.65.1877
10.1245/s10434-012-2569-y
10.1245/s10434-014-4034-6
10.1097/00000658-199409000-00015
10.1016/S1470-2045(13)70166-9
10.1245/s10434-016-5420-z
10.1002/cncr.23068
10.1093/jnci/djp175
10.1002/cncr.22540
10.1016/0960-7404(93)90064-6
10.1097/PAS.0b013e31806841f6
10.1016/j.critrevonc.2016.11.011
10.1371/journal.pone.0071915
10.1186/s12916-015-0385-5
10.1038/sj.bjc.6604174
10.1200/JCO.1999.17.2.460
10.1093/jnci/djx135
10.1007/s10549-015-3528-7
10.1200/JCO.1995.13.5.1144
10.1245/s10434-014-4279-0
10.1200/JCO.2005.05.188
10.1245/s10434-016-5463-1
10.1001/jama.1994.03520120057031
10.1097/MD.0000000000004614
10.1001/archinte.163.1.49
10.1245/s10434-016-5177-4
10.1245/s10434-016-5310-4
10.1186/1472-6874-14-102
10.1245/s10434-015-4527-y
10.1093/jnci/djp281
10.1097/00000658-199907000-00011
10.1056/NEJM199810013391401
10.1002/cncr.25152
10.1200/JCO.2014.55.7827
10.1245/s10434-015-5052-8
10.1126/science.aai8515
10.3322/caac.21320
10.1097/00000658-189407000-00075
10.1126/science.aal3622
10.1016/j.clbc.2017.10.007
10.1158/0008-5472.CAN-06-1392
10.1001/jama.2011.90
10.1200/JCO.2005.03.3472
10.1200/JCO.2005.08.001
10.1002/cncr.29766
10.1007/s10549-016-4062-y
10.1016/j.ejso.2015.11.019
10.1200/JCO.2014.58.9838
10.1097/SLA.0000000000000558
10.1245/s10434-007-9494-5
10.1245/s10434-012-2484-2
10.1126/science.aal3662
10.3322/caac.21412
10.1097/SLA.0b013e31812e6a73
10.1001/jama.2014.17322
ContentType Journal Article
Copyright Springer Science+Business Media B.V., part of Springer Nature 2018
Clinical & Experimental Metastasis is a copyright of Springer, (2018). All Rights Reserved.
Copyright_xml – notice: Springer Science+Business Media B.V., part of Springer Nature 2018
– notice: Clinical & Experimental Metastasis is a copyright of Springer, (2018). All Rights Reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7X7
7XB
88E
88I
8FE
8FG
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
M0S
M1P
M2P
P5Z
P62
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1007/s10585-018-9902-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Science Database
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Collection
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-7276
EndPage 454
ExternalDocumentID 29796854
10_1007_s10585_018_9902_1
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
-4W
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29B
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5C9
5GY
5QI
5RE
5VS
67Z
6NX
7X7
88E
88I
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LK5
LLZTM
M1P
M2P
M4Y
M7R
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P62
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SBY
SCLPG
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7XB
8FK
ABRTQ
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c372t-3b9e0571ac9fb3fc0d60a88ac9ad4b8ffb419b60f0ed98e82dd835d21fa3710f3
IEDL.DBID 7X7
ISSN 0262-0898
1573-7276
IngestDate Tue Aug 05 11:03:23 EDT 2025
Sat Aug 16 08:11:16 EDT 2025
Wed Feb 19 02:35:58 EST 2025
Tue Jul 01 03:11:28 EDT 2025
Thu Apr 24 23:12:39 EDT 2025
Fri Feb 21 02:30:25 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5-6
Keywords Axilla
Breast cancer sentinel lymph nodes
Metastasis
Racial disparities
Targeted dissection
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-3b9e0571ac9fb3fc0d60a88ac9ad4b8ffb419b60f0ed98e82dd835d21fa3710f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
PMID 29796854
PQID 2042950211
PQPubID 30909
PageCount 12
ParticipantIDs proquest_miscellaneous_2045269295
proquest_journals_2042950211
pubmed_primary_29796854
crossref_citationtrail_10_1007_s10585_018_9902_1
crossref_primary_10_1007_s10585_018_9902_1
springer_journals_10_1007_s10585_018_9902_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-08-01
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 08
  year: 2018
  text: 2018-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: Netherlands
PublicationSubtitle Official Journal of the Metastasis Research Society
PublicationTitle Clinical & experimental metastasis
PublicationTitleAbbrev Clin Exp Metastasis
PublicationTitleAlternate Clin Exp Metastasis
PublicationYear 2018
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References DeSantisCEBreast cancer statistics, 2015: convergence of incidence rates between black and white womenCA Cancer J Clin201666314210.3322/caac.21320
BrownASHistologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentCancer20101162878288310.1002/cncr.25066
AlvaradoRThe role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancerAnn Surg Oncol2012193177318410.1245/s10434-012-2484-2
WeissAExpanding implementation of ACOSOG Z0011 in surgeon practiceClin Breast Cancer201710.1016/j.clbc.2017.10.00729100726
HoshidaTImaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implicationsCancer Res200666806580751:CAS:528:DC%2BD28XotFWqtL8%3D10.1158/0008-5472.CAN-06-1392
GiulianoAELymphatic mapping and sentinel lymphadenectomy for breast cancerAnn Surg19942203913981:STN:280:DyaK2cznvFyksA%3D%3D10.1097/00000658-199409000-00015discussion 398–401
Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and hispanic groups by state and place: 2007–2011. U.S. Census Bureau. https://www.census.gov/prod/2013pubs/acsbr11-17.pdf. Accessed 30 April 2017
BrownMLymph node blood vessels provide exit routes for metastatic tumor cell dissemination in miceScience2018359140814111:CAS:528:DC%2BC1cXltFehtb0%3D10.1126/science.aal3662
KuererHMIncidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapyAnn Surg199923072781:STN:280:DyaK1MzisFKhtA%3D%3D10.1097/00000658-199907000-00011
VisscherDWClinicopathologic features of breast cancers that develop in women with previous benign breast diseaseCancer201612237838510.1002/cncr.29766
Ward BW et al. Early release of selected estimates based on data from the 2014 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201503.pdf. Accessed 30 April 2017
CareyLARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA2006295249225021:CAS:528:DC%2BD28XlsV2rtLw%3D10.1001/jama.295.21.2492
AkinyemijuTMooreJXAltekruseSFBreast cancer survival in African–American women by hormone receptor subtypesBreast Cancer Res Treat20151532112181:CAS:528:DC%2BC2MXhtlelsbzL10.1007/s10549-015-3528-7
LindnerRMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyPLoS ONE20138e7191510.1371/journal.pone.0071915
CaudleASImproved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissectionJ Clin Oncol201634107210781:CAS:528:DC%2BC2sXnvF2ktw%3D%3D10.1200/JCO.2015.64.0094
KragDNSurgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurg Oncol199323353391:STN:280:DyaK2c7nslegtQ%3D%3D10.1016/0960-7404(93)90064-6discussion 340
FolkmanJTumor angiogenesis factorCancer Res19743421092113
QuietCANatural history of node-negative breast cancer: a study of 826 patients with long-term follow-upJ Clin Oncol199513114411511:STN:280:DyaK2M3ls12gtw%3D%3D10.1200/JCO.1995.13.5.1144
BougheyJCSentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trialJAMA2013310145514611:CAS:528:DC%2BC3sXhs1Cnt7zP10.1001/jama.2013.278932
FisherBLaboratory and clinical research in breast cancer–a personal adventure: the David A. Karnofsky memorial lectureCancer Res198040386338741:STN:280:DyaL3M7jsFCktQ%3D%3D
StackerSALymphangiogenesis and lymphatic vessel remodelling in cancerNat Rev Cancer2014141591721:CAS:528:DC%2BC2cXisVaksbk%3D10.1038/nrc3677
LymanGHAppropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancerJ Clin Oncol20153323223410.1200/JCO.2014.58.9838
CopsonEEthnicity and outcome of young breast cancer patients in the United Kingdom: the POSH studyBr J Cancer20141102302411:STN:280:DC%2BC2c%2FovFamuw%3D%3D10.1038/bjc.2013.650
KuererHMClinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyJ Clin Oncol1999174604691:CAS:528:DyaK1MXht1Wmur4%3D10.1200/JCO.1999.17.2.460
KragDNSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialLancet Oncol20101192793310.1016/S1470-2045(10)70207-2
GiulianoAELocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trialAnn Surg201626441342010.1097/SLA.0000000000001863
GiulianoAEAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialJAMA20113055695751:CAS:528:DC%2BC3MXhvVymtrg%3D10.1001/jama.2011.90
KragDNSurgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trialJ Natl Cancer Inst20091011356136210.1093/jnci/djp281
FisherBEffect of preoperative chemotherapy on the outcome of women with operable breast cancerJ Clin Oncol199816267226851:CAS:528:DyaK1cXlsFCgurg%3D10.1200/JCO.1998.16.8.2672
LymanGHSentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol2014321365138310.1200/JCO.2013.54.1177
RapitiEOpportunities for improving triple-negative breast cancer outcomes: results of a population-based studyCancer Med2017652653610.1002/cam4.998
EleyJWRacial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival StudyJAMA19942729479541:STN:280:DyaK2czms1Sguw%3D%3D10.1001/jama.1994.03520120057031
GalimbertiVSentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentEur J Surg Oncol2016423613681:STN:280:DC%2BC28rosFKruw%3D%3D10.1016/j.ejso.2015.11.019
ChoyNInitial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patientsAnn Surg Oncol20152237738210.1245/s10434-014-4034-6
CarvalhoFMGeographic differences in the distribution of molecular subtypes of breast cancer in BrazilBMC Womens Health20141410210.1186/1472-6874-14-102
TroesterMARacial differences in PAM50 subtypes in the Carolina Breast Cancer StudyJ Natl Cancer Inst201811017618210.1093/jnci/djx135
NewmanLAThe 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancerAnn Surg Oncol20152287488210.1245/s10434-014-4279-0
TsaoMWA population-based study of the effects of a regional guideline for completion axillary lymph node dissection on axillary surgery in patients with breast cancerAnn Surg Oncol2016233354336410.1245/s10434-016-5310-4
HuoDComparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome AtlasJAMA Oncol201731654166210.1001/jamaoncol.2017.0595
BowenRLEarly onset of breast cancer in a group of British black womenBr J Cancer2008982772811:STN:280:DC%2BD1c%2Fmt1amtw%3D%3D10.1038/sj.bjc.6604174
BoileauJFSentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJ Clin Oncol20153325826410.1200/JCO.2014.55.7827
CaudleASUse of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons membersAnn Surg Oncol2017242925293410.1245/s10434-017-5958-4
Surveillance EaERP, Institute NC. Surveillance, Epidemiology and End Results Fast Stats. SEER Website. https://seer.cancer.gov/faststats/selections.php?#Output. Accessed 30 April 2017
LymanGHAmerican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancerJ Clin Oncol2005237703772010.1200/JCO.2005.08.001
NewmanLAMeta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic statusJ Clin Oncol2006241342134910.1200/JCO.2005.03.3472
Lopez-GarciaMABreast cancer precursors revisited: molecular features and progression pathwaysHistopathology20105717119210.1111/j.1365-2559.2010.03568.x
PereiraERLymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in miceScience2018359140314071:CAS:528:DC%2BC1cXltFehtbc%3D10.1126/science.aal3622
MohammedRAImproved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequencesAm J Surg Pathol2007311825183310.1097/PAS.0b013e31806841f6
ShahRThe association amongst ‘triple negative’ breast cancers, lymph node metastasis, disease free and overall survivalJ Cancer Sci201525
SolaMComplete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000Ann Surg Oncol20132012012710.1245/s10434-012-2569-y
AlbainKSRacial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology GroupJ Natl Cancer Inst200910198499210.1093/jnci/djp175
DominiciLSCytologically proven axillary lymph node meta
JW Eley (9902_CR61) 1994; 272
RL Bowen (9902_CR83) 2008; 98
AS Caudle (9902_CR21) 2016; 34
CI Li (9902_CR68) 2003; 163
MW Tsao (9902_CR35) 2016; 23
GH Lyman (9902_CR18) 2015; 33
KS Albain (9902_CR63) 2009; 101
FO Ademuyiwa (9902_CR79) 2017; 161
B Fisher (9902_CR37) 1998; 16
LA Newman (9902_CR62) 2006; 24
G Canavese (9902_CR32) 2016; 23
R Lindner (9902_CR77) 2013; 8
J Folkman (9902_CR4) 1974; 34
LA Newman (9902_CR67) 2016; 34
T Akinyemiju (9902_CR75) 2015; 153
JF Robertson (9902_CR33) 2017; 110
MA Troester (9902_CR73) 2018; 110
E Copson (9902_CR84) 2014; 110
HM Kuerer (9902_CR39) 1999; 230
M Donker (9902_CR47) 2015; 261
AS Caudle (9902_CR51) 2017; 24
DN Krag (9902_CR26) 2009; 101
B Fisher (9902_CR3) 1980; 40
LA Newman (9902_CR65) 2017; 152
BA Kohler (9902_CR70) 2015; 107
WS Halsted (9902_CR2) 1894; 20
LA Carey (9902_CR72) 2006; 295
G Zavagno (9902_CR31) 2008; 247
EP Mamounas (9902_CR19) 2005; 23
AE Giuliano (9902_CR13) 1994; 220
AS Caudle (9902_CR46) 2015; 150
AE Giuliano (9902_CR15) 2011; 305
DN Krag (9902_CR14) 1993; 2
RF Parra van la (9902_CR36) 2016; 18
JL Oh (9902_CR53) 2007; 110
LA Newman (9902_CR69) 2015; 22
T Kuehn (9902_CR45) 2013; 14
D Krag (9902_CR25) 1998; 339
AS Brown (9902_CR52) 2010; 116
T Hoshida (9902_CR7) 2006; 66
LS Dominici (9902_CR40) 2010; 116
DN Krag (9902_CR27) 2010; 11
D Huo (9902_CR80) 2017; 3
EJ Diego (9902_CR50) 2016; 23
R Virchow (9902_CR1) 1860
ER Pereira (9902_CR9) 2018; 359
GH Lyman (9902_CR16) 2005; 23
M Sola (9902_CR30) 2013; 20
AV Barrio (9902_CR23) 2016; 23
JF Boileau (9902_CR43) 2015; 33
R Alvarado (9902_CR42) 2012; 19
MA Lopez-Garcia (9902_CR81) 2010; 57
K Naxerova (9902_CR11) 2017; 357
A Weiss (9902_CR34) 2017
CE DeSantis (9902_CR56) 2017; 67
DW Visscher (9902_CR82) 2016; 122
American Cancer Society (9902_CR60) 2017
RA Mohammed (9902_CR5) 2007; 31
9902_CR66
AS Caudle (9902_CR44) 2015; 13
J Iqbal (9902_CR59) 2015; 313
CH Kroenke (9902_CR76) 2014; 144
AE Giuliano (9902_CR28) 2016; 264
SD Nathanson (9902_CR6) 2009; 16
LA Newman (9902_CR64) 2017; 24
ML Plasilova (9902_CR74) 2016; 95
E Jiagge (9902_CR87) 2016; 23
M Brown (9902_CR10) 2018; 359
N Choy (9902_CR48) 2015; 22
R Shah (9902_CR24) 2015; 2
SA Stacker (9902_CR8) 2014; 14
JC Boughey (9902_CR22) 2013; 310
SD Nathanson (9902_CR20) 2007; 14
CE DeSantis (9902_CR55) 2016; 66
T Keenan (9902_CR78) 2015; 33
E Rapiti (9902_CR85) 2017; 6
FM Carvalho (9902_CR86) 2014; 14
J Shen (9902_CR41) 2007; 109
HM Kuerer (9902_CR38) 1999; 17
CA Quiet (9902_CR12) 1995; 13
D Plecha (9902_CR49) 2015; 22
KC Amirikia (9902_CR71) 2011; 117
9902_CR58
9902_CR57
GH Lyman (9902_CR17) 2014; 32
V Galimberti (9902_CR29) 2013; 14
V Galimberti (9902_CR54) 2016; 42
References_xml – reference: ChoyNInitial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patientsAnn Surg Oncol20152237738210.1245/s10434-014-4034-6
– reference: AkinyemijuTMooreJXAltekruseSFBreast cancer survival in African–American women by hormone receptor subtypesBreast Cancer Res Treat20151532112181:CAS:528:DC%2BC2MXhtlelsbzL10.1007/s10549-015-3528-7
– reference: StackerSALymphangiogenesis and lymphatic vessel remodelling in cancerNat Rev Cancer2014141591721:CAS:528:DC%2BC2cXisVaksbk%3D10.1038/nrc3677
– reference: FisherBLaboratory and clinical research in breast cancer–a personal adventure: the David A. Karnofsky memorial lectureCancer Res198040386338741:STN:280:DyaL3M7jsFCktQ%3D%3D
– reference: QuietCANatural history of node-negative breast cancer: a study of 826 patients with long-term follow-upJ Clin Oncol199513114411511:STN:280:DyaK2M3ls12gtw%3D%3D10.1200/JCO.1995.13.5.1144
– reference: KuehnTSentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyLancet Oncol20131460961810.1016/S1470-2045(13)70166-9
– reference: CaudleASUse of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons membersAnn Surg Oncol2017242925293410.1245/s10434-017-5958-4
– reference: JiaggeEComparative analysis of breast cancer phenotypes in African American, White American, and West Versus East African patients: correlation between African ancestry and triple-negative breast cancerAnn Surg Oncol2016233843384910.1245/s10434-016-5420-z
– reference: KuererHMClinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyJ Clin Oncol1999174604691:CAS:528:DyaK1MXht1Wmur4%3D10.1200/JCO.1999.17.2.460
– reference: NewmanLAParsing the etiology of breast cancer disparitiesJ Clin Oncol201634101310141:CAS:528:DC%2BC2sXnvFOhug%3D%3D10.1200/JCO.2015.65.1877
– reference: American Cancer SocietyBreast cancer facts & Figs. 2017–20182017AtlantaAmerican Cancer Society
– reference: BrownMLymph node blood vessels provide exit routes for metastatic tumor cell dissemination in miceScience2018359140814111:CAS:528:DC%2BC1cXltFehtb0%3D10.1126/science.aal3662
– reference: LymanGHAppropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancerJ Clin Oncol20153323223410.1200/JCO.2014.58.9838
– reference: KroenkeCHRace and breast cancer survival by intrinsic subtype based on PAM50 gene expressionBreast Cancer Res Treat20141446896991:CAS:528:DC%2BC2cXjslOrurg%3D10.1007/s10549-014-2899-5
– reference: MohammedRAImproved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequencesAm J Surg Pathol2007311825183310.1097/PAS.0b013e31806841f6
– reference: CaudleASKuererHMTargeting and limiting surgery for patients with node-positive breast cancerBMC Med20151314910.1186/s12916-015-0385-5
– reference: DeSantisCEBreast cancer statistics, 2015: convergence of incidence rates between black and white womenCA Cancer J Clin201666314210.3322/caac.21320
– reference: GiulianoAELymphatic mapping and sentinel lymphadenectomy for breast cancerAnn Surg19942203913981:STN:280:DyaK2cznvFyksA%3D%3D10.1097/00000658-199409000-00015discussion 398–401
– reference: KragDNSurgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trialJ Natl Cancer Inst20091011356136210.1093/jnci/djp281
– reference: CanaveseGSentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trialAnn Surg Oncol2016232494250010.1245/s10434-016-5177-4
– reference: NathansonSDThe role of lymph node metastasis in the systemic dissemination of breast cancerAnn Surg Oncol2009163396340510.1245/s10434-009-0659-2
– reference: CaudleASSelective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trialJAMA Surg201515013714310.1001/jamasurg.2014.1086
– reference: NewmanLAKaljeeLMHealth disparities and triple-negative breast cancer in African American women: a reviewJAMA Surg201715248549310.1001/jamasurg.2017.0005
– reference: ShahRThe association amongst ‘triple negative’ breast cancers, lymph node metastasis, disease free and overall survivalJ Cancer Sci201525
– reference: LymanGHSentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol2014321365138310.1200/JCO.2013.54.1177
– reference: VisscherDWClinicopathologic features of breast cancers that develop in women with previous benign breast diseaseCancer201612237838510.1002/cncr.29766
– reference: GalimbertiVSentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentEur J Surg Oncol2016423613681:STN:280:DC%2BC28rosFKruw%3D%3D10.1016/j.ejso.2015.11.019
– reference: FisherBEffect of preoperative chemotherapy on the outcome of women with operable breast cancerJ Clin Oncol199816267226851:CAS:528:DyaK1cXlsFCgurg%3D10.1200/JCO.1998.16.8.2672
– reference: FolkmanJTumor angiogenesis factorCancer Res19743421092113
– reference: MamounasEPSentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27J Clin Oncol2005232694270210.1200/JCO.2005.05.188
– reference: HoshidaTImaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implicationsCancer Res200666806580751:CAS:528:DC%2BD28XotFWqtL8%3D10.1158/0008-5472.CAN-06-1392
– reference: BarrioAVHow often is treatment effect identified in axillary nodes with a pathologic complete response after neoadjuvant chemotherapy?Ann Surg Oncol2016233475348010.1245/s10434-016-5463-1
– reference: AdemuyiwaFODifferences in the mutational landscape of triple-negative breast cancer in African Americans and CaucasiansBreast Cancer Res Treat20171614914991:CAS:528:DC%2BC28XitVKjtrnI10.1007/s10549-016-4062-y
– reference: RapitiEOpportunities for improving triple-negative breast cancer outcomes: results of a population-based studyCancer Med2017652653610.1002/cam4.998
– reference: NewmanLABreast cancer disparities: socioeconomic factors versus biologyAnn Surg Oncol2017242869287510.1245/s10434-017-5977-1
– reference: HalstedWSI. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894Ann Surg1894204975551:STN:280:DC%2BD2srksFWmsQ%3D%3D10.1097/00000658-189407000-00075
– reference: KohlerBAAnnual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and stateJ Natl Cancer Inst2015107djv04810.1093/jnci/djv048
– reference: TroesterMARacial differences in PAM50 subtypes in the Carolina Breast Cancer StudyJ Natl Cancer Inst201811017618210.1093/jnci/djx135
– reference: van la ParraRFKuererHMSelective elimination of breast cancer surgery in exceptional responders: historical perspective and current trialsBreast Cancer Res2016182810.1186/s13058-016-0684-6
– reference: Surveillance EaERP, Institute NC. Surveillance, Epidemiology and End Results Fast Stats. SEER Website. https://seer.cancer.gov/faststats/selections.php?#Output. Accessed 30 April 2017
– reference: Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and hispanic groups by state and place: 2007–2011. U.S. Census Bureau. https://www.census.gov/prod/2013pubs/acsbr11-17.pdf. Accessed 30 April 2017
– reference: EleyJWRacial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival StudyJAMA19942729479541:STN:280:DyaK2czms1Sguw%3D%3D10.1001/jama.1994.03520120057031
– reference: LindnerRMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyPLoS ONE20138e7191510.1371/journal.pone.0071915
– reference: CopsonEEthnicity and outcome of young breast cancer patients in the United Kingdom: the POSH studyBr J Cancer20141102302411:STN:280:DC%2BC2c%2FovFamuw%3D%3D10.1038/bjc.2013.650
– reference: PlasilovaMLFeatures of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer databaseMedicine201695e461410.1097/MD.0000000000004614
– reference: GalimbertiVAxillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23 – 01): a phase 3 randomised controlled trialLancet Oncol20131429730510.1016/S1470-2045(13)70035-4
– reference: Ward BW et al. Early release of selected estimates based on data from the 2014 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201503.pdf. Accessed 30 April 2017
– reference: NaxerovaKOrigins of lymphatic and distant metastases in human colorectal cancerScience201735755601:CAS:528:DC%2BC2sXhtFans7fJ10.1126/science.aai8515
– reference: GiulianoAEAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialJAMA20113055695751:CAS:528:DC%2BC3MXhvVymtrg%3D10.1001/jama.2011.90
– reference: ShenJFeasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastasesCancer20071091255126310.1002/cncr.22540
– reference: CareyLARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA2006295249225021:CAS:528:DC%2BD28XlsV2rtLw%3D10.1001/jama.295.21.2492
– reference: KragDNSurgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurg Oncol199323353391:STN:280:DyaK2c7nslegtQ%3D%3D10.1016/0960-7404(93)90064-6discussion 340
– reference: DiegoEJAxillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodesAnn Surg Oncol2016231549155310.1245/s10434-015-5052-8
– reference: BowenRLEarly onset of breast cancer in a group of British black womenBr J Cancer2008982772811:STN:280:DC%2BD1c%2Fmt1amtw%3D%3D10.1038/sj.bjc.6604174
– reference: PereiraERLymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in miceScience2018359140314071:CAS:528:DC%2BC1cXltFehtbc%3D10.1126/science.aal3622
– reference: GiulianoAELocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trialAnn Surg201626441342010.1097/SLA.0000000000001863
– reference: TsaoMWA population-based study of the effects of a regional guideline for completion axillary lymph node dissection on axillary surgery in patients with breast cancerAnn Surg Oncol2016233354336410.1245/s10434-016-5310-4
– reference: NathansonSDPreoperative identification of the sentinel lymph node in breast cancerAnn Surg Oncol2007143102311010.1245/s10434-007-9494-5
– reference: CaudleASImproved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissectionJ Clin Oncol201634107210781:CAS:528:DC%2BC2sXnvF2ktw%3D%3D10.1200/JCO.2015.64.0094
– reference: KragDNSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialLancet Oncol20101192793310.1016/S1470-2045(10)70207-2
– reference: KragDThe sentinel node in breast cancer–a multicenter validation studyN Engl J Med19983399419461:STN:280:DyaK1cvhvVKntg%3D%3D10.1056/NEJM199810013391401
– reference: VirchowRCellular pathology: as based upon physiological and pathological histology, twenty lectures delivered in the Pathological Institute of Berlin during the months of February, March and April, 18581860LondonJohn Churchill
– reference: SolaMComplete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000Ann Surg Oncol20132012012710.1245/s10434-012-2569-y
– reference: KeenanTComparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrenceJ Clin Oncol201533362136271:CAS:528:DC%2BC28XhtVakt73I10.1200/JCO.2015.62.2126
– reference: AmirikiaKCHigher population-based incidence rates of triple-negative breast cancer among young African-American women: Implications for breast cancer screening recommendationsCancer20111172747275310.1002/cncr.25862
– reference: OhJLPlacement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapyCancer20071102420242710.1002/cncr.23068
– reference: KuererHMIncidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapyAnn Surg199923072781:STN:280:DyaK1MzisFKhtA%3D%3D10.1097/00000658-199907000-00011
– reference: DeSantisCEBreast cancer statistics, 2017, racial disparity in mortality by stateCA Cancer J Clin20176743944810.3322/caac.21412
– reference: IqbalJDifferences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United StatesJAMA20153131651731:CAS:528:DC%2BC2MXit1Ons70%3D10.1001/jama.2014.17322
– reference: ZavagnoGA Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trialAnn Surg200824720721310.1097/SLA.0b013e31812e6a73
– reference: LiCIMaloneKEDalingJRDifferences in breast cancer stage, treatment, and survival by race and ethnicityArch Intern Med2003163495610.1001/archinte.163.1.49
– reference: Lopez-GarciaMABreast cancer precursors revisited: molecular features and progression pathwaysHistopathology20105717119210.1111/j.1365-2559.2010.03568.x
– reference: LymanGHAmerican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancerJ Clin Oncol2005237703772010.1200/JCO.2005.08.001
– reference: NewmanLAMeta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic statusJ Clin Oncol2006241342134910.1200/JCO.2005.03.3472
– reference: RobertsonJFTreatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trialsCrit Rev Oncol Hematol201711074801:STN:280:DC%2BC1c7nvFerug%3D%3D10.1016/j.critrevonc.2016.11.011
– reference: PlechaDImproving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodesAnn Surg Oncol2015224241424610.1245/s10434-015-4527-y
– reference: CarvalhoFMGeographic differences in the distribution of molecular subtypes of breast cancer in BrazilBMC Womens Health20141410210.1186/1472-6874-14-102
– reference: WeissAExpanding implementation of ACOSOG Z0011 in surgeon practiceClin Breast Cancer201710.1016/j.clbc.2017.10.00729100726
– reference: DonkerMMarking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedureAnn Surg201526137838210.1097/SLA.0000000000000558
– reference: BougheyJCSentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trialJAMA2013310145514611:CAS:528:DC%2BC3sXhs1Cnt7zP10.1001/jama.2013.278932
– reference: DominiciLSCytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancerCancer20101162884288910.1002/cncr.25152
– reference: HuoDComparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome AtlasJAMA Oncol201731654166210.1001/jamaoncol.2017.0595
– reference: AlvaradoRThe role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancerAnn Surg Oncol2012193177318410.1245/s10434-012-2484-2
– reference: NewmanLAThe 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancerAnn Surg Oncol20152287488210.1245/s10434-014-4279-0
– reference: AlbainKSRacial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology GroupJ Natl Cancer Inst200910198499210.1093/jnci/djp175
– reference: BrownASHistologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentCancer20101162878288310.1002/cncr.25066
– reference: BoileauJFSentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJ Clin Oncol20153325826410.1200/JCO.2014.55.7827
– volume: 3
  start-page: 1654
  year: 2017
  ident: 9902_CR80
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2017.0595
– ident: 9902_CR57
– volume: 11
  start-page: 927
  year: 2010
  ident: 9902_CR27
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(10)70207-2
– volume: 107
  start-page: djv048
  year: 2015
  ident: 9902_CR70
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djv048
– volume: 14
  start-page: 159
  year: 2014
  ident: 9902_CR8
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3677
– volume: 150
  start-page: 137
  year: 2015
  ident: 9902_CR46
  publication-title: JAMA Surg
  doi: 10.1001/jamasurg.2014.1086
– volume: 24
  start-page: 2925
  year: 2017
  ident: 9902_CR51
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-017-5958-4
– volume-title: Breast cancer facts & Figs. 2017–2018
  year: 2017
  ident: 9902_CR60
– volume: 116
  start-page: 2878
  year: 2010
  ident: 9902_CR52
  publication-title: Cancer
  doi: 10.1002/cncr.25066
– volume: 6
  start-page: 526
  year: 2017
  ident: 9902_CR85
  publication-title: Cancer Med
  doi: 10.1002/cam4.998
– volume: 117
  start-page: 2747
  year: 2011
  ident: 9902_CR71
  publication-title: Cancer
  doi: 10.1002/cncr.25862
– volume: 295
  start-page: 2492
  year: 2006
  ident: 9902_CR72
  publication-title: JAMA
  doi: 10.1001/jama.295.21.2492
– volume: 24
  start-page: 2869
  year: 2017
  ident: 9902_CR64
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-017-5977-1
– volume: 34
  start-page: 1072
  year: 2016
  ident: 9902_CR21
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.64.0094
– volume: 264
  start-page: 413
  year: 2016
  ident: 9902_CR28
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000001863
– volume: 40
  start-page: 3863
  year: 1980
  ident: 9902_CR3
  publication-title: Cancer Res
– volume: 18
  start-page: 28
  year: 2016
  ident: 9902_CR36
  publication-title: Breast Cancer Res
  doi: 10.1186/s13058-016-0684-6
– volume: 110
  start-page: 230
  year: 2014
  ident: 9902_CR84
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.650
– volume: 32
  start-page: 1365
  year: 2014
  ident: 9902_CR17
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2013.54.1177
– volume: 310
  start-page: 1455
  year: 2013
  ident: 9902_CR22
  publication-title: JAMA
  doi: 10.1001/jama.2013.278932
– volume: 33
  start-page: 3621
  year: 2015
  ident: 9902_CR78
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.62.2126
– volume: 14
  start-page: 297
  year: 2013
  ident: 9902_CR29
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(13)70035-4
– volume: 57
  start-page: 171
  year: 2010
  ident: 9902_CR81
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2010.03568.x
– volume: 16
  start-page: 3396
  year: 2009
  ident: 9902_CR6
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-009-0659-2
– volume: 144
  start-page: 689
  year: 2014
  ident: 9902_CR76
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-014-2899-5
– volume: 152
  start-page: 485
  year: 2017
  ident: 9902_CR65
  publication-title: JAMA Surg
  doi: 10.1001/jamasurg.2017.0005
– volume: 16
  start-page: 2672
  year: 1998
  ident: 9902_CR37
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1998.16.8.2672
– volume: 34
  start-page: 1013
  year: 2016
  ident: 9902_CR67
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2015.65.1877
– volume: 20
  start-page: 120
  year: 2013
  ident: 9902_CR30
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-012-2569-y
– ident: 9902_CR58
– volume: 22
  start-page: 377
  year: 2015
  ident: 9902_CR48
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-4034-6
– volume: 220
  start-page: 391
  year: 1994
  ident: 9902_CR13
  publication-title: Ann Surg
  doi: 10.1097/00000658-199409000-00015
– volume: 14
  start-page: 609
  year: 2013
  ident: 9902_CR45
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(13)70166-9
– volume: 23
  start-page: 3843
  year: 2016
  ident: 9902_CR87
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-016-5420-z
– volume: 110
  start-page: 2420
  year: 2007
  ident: 9902_CR53
  publication-title: Cancer
  doi: 10.1002/cncr.23068
– volume: 101
  start-page: 984
  year: 2009
  ident: 9902_CR63
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djp175
– volume: 109
  start-page: 1255
  year: 2007
  ident: 9902_CR41
  publication-title: Cancer
  doi: 10.1002/cncr.22540
– volume: 2
  start-page: 335
  year: 1993
  ident: 9902_CR14
  publication-title: Surg Oncol
  doi: 10.1016/0960-7404(93)90064-6
– volume: 31
  start-page: 1825
  year: 2007
  ident: 9902_CR5
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0b013e31806841f6
– volume: 110
  start-page: 74
  year: 2017
  ident: 9902_CR33
  publication-title: Crit Rev Oncol Hematol
  doi: 10.1016/j.critrevonc.2016.11.011
– volume: 8
  start-page: e71915
  year: 2013
  ident: 9902_CR77
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0071915
– volume-title: Cellular pathology: as based upon physiological and pathological histology, twenty lectures delivered in the Pathological Institute of Berlin during the months of February, March and April, 1858
  year: 1860
  ident: 9902_CR1
– volume: 13
  start-page: 149
  year: 2015
  ident: 9902_CR44
  publication-title: BMC Med
  doi: 10.1186/s12916-015-0385-5
– volume: 98
  start-page: 277
  year: 2008
  ident: 9902_CR83
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6604174
– volume: 17
  start-page: 460
  year: 1999
  ident: 9902_CR38
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1999.17.2.460
– volume: 110
  start-page: 176
  year: 2018
  ident: 9902_CR73
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djx135
– volume: 153
  start-page: 211
  year: 2015
  ident: 9902_CR75
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-015-3528-7
– volume: 13
  start-page: 1144
  year: 1995
  ident: 9902_CR12
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1995.13.5.1144
– volume: 22
  start-page: 874882
  year: 2015
  ident: 9902_CR69
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-014-4279-0
– volume: 23
  start-page: 2694
  year: 2005
  ident: 9902_CR19
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.05.188
– volume: 23
  start-page: 3475
  year: 2016
  ident: 9902_CR23
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-016-5463-1
– volume: 272
  start-page: 947
  year: 1994
  ident: 9902_CR61
  publication-title: JAMA
  doi: 10.1001/jama.1994.03520120057031
– volume: 95
  start-page: e4614
  year: 2016
  ident: 9902_CR74
  publication-title: Medicine
  doi: 10.1097/MD.0000000000004614
– volume: 163
  start-page: 49
  year: 2003
  ident: 9902_CR68
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.163.1.49
– volume: 23
  start-page: 2494
  year: 2016
  ident: 9902_CR32
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-016-5177-4
– volume: 23
  start-page: 3354
  year: 2016
  ident: 9902_CR35
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-016-5310-4
– volume: 34
  start-page: 21092113
  year: 1974
  ident: 9902_CR4
  publication-title: Cancer Res
– volume: 14
  start-page: 102
  year: 2014
  ident: 9902_CR86
  publication-title: BMC Womens Health
  doi: 10.1186/1472-6874-14-102
– volume: 22
  start-page: 4241
  year: 2015
  ident: 9902_CR49
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-015-4527-y
– volume: 101
  start-page: 1356
  year: 2009
  ident: 9902_CR26
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djp281
– volume: 230
  start-page: 72
  year: 1999
  ident: 9902_CR39
  publication-title: Ann Surg
  doi: 10.1097/00000658-199907000-00011
– volume: 339
  start-page: 941
  year: 1998
  ident: 9902_CR25
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199810013391401
– volume: 116
  start-page: 2884
  year: 2010
  ident: 9902_CR40
  publication-title: Cancer
  doi: 10.1002/cncr.25152
– volume: 33
  start-page: 258
  year: 2015
  ident: 9902_CR43
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.55.7827
– volume: 23
  start-page: 1549
  year: 2016
  ident: 9902_CR50
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-015-5052-8
– volume: 357
  start-page: 55
  year: 2017
  ident: 9902_CR11
  publication-title: Science
  doi: 10.1126/science.aai8515
– volume: 66
  start-page: 31
  year: 2016
  ident: 9902_CR55
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21320
– volume: 20
  start-page: 497
  year: 1894
  ident: 9902_CR2
  publication-title: Ann Surg
  doi: 10.1097/00000658-189407000-00075
– volume: 359
  start-page: 1403
  year: 2018
  ident: 9902_CR9
  publication-title: Science
  doi: 10.1126/science.aal3622
– year: 2017
  ident: 9902_CR34
  publication-title: Clin Breast Cancer
  doi: 10.1016/j.clbc.2017.10.007
– volume: 66
  start-page: 8065
  year: 2006
  ident: 9902_CR7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-1392
– volume: 305
  start-page: 569
  year: 2011
  ident: 9902_CR15
  publication-title: JAMA
  doi: 10.1001/jama.2011.90
– volume: 24
  start-page: 1342
  year: 2006
  ident: 9902_CR62
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.03.3472
– volume: 23
  start-page: 7703
  year: 2005
  ident: 9902_CR16
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.08.001
– volume: 122
  start-page: 378
  year: 2016
  ident: 9902_CR82
  publication-title: Cancer
  doi: 10.1002/cncr.29766
– volume: 161
  start-page: 491
  year: 2017
  ident: 9902_CR79
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-016-4062-y
– volume: 42
  start-page: 361
  year: 2016
  ident: 9902_CR54
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2015.11.019
– volume: 2
  start-page: 5
  year: 2015
  ident: 9902_CR24
  publication-title: J Cancer Sci
– volume: 33
  start-page: 232
  year: 2015
  ident: 9902_CR18
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.58.9838
– volume: 261
  start-page: 378
  year: 2015
  ident: 9902_CR47
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000000558
– volume: 14
  start-page: 3102
  year: 2007
  ident: 9902_CR20
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-007-9494-5
– volume: 19
  start-page: 3177
  year: 2012
  ident: 9902_CR42
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-012-2484-2
– volume: 359
  start-page: 1408
  year: 2018
  ident: 9902_CR10
  publication-title: Science
  doi: 10.1126/science.aal3662
– ident: 9902_CR66
– volume: 67
  start-page: 439
  year: 2017
  ident: 9902_CR56
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21412
– volume: 247
  start-page: 207
  year: 2008
  ident: 9902_CR31
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31812e6a73
– volume: 313
  start-page: 165
  year: 2015
  ident: 9902_CR59
  publication-title: JAMA
  doi: 10.1001/jama.2014.17322
SSID ssj0004778
Score 2.3949137
SecondaryResourceType review_article
Snippet Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 443
SubjectTerms Biomedical and Life Sciences
Biomedicine
Biopsy
Blood vessels
Breast cancer
Breast Neoplasms - epidemiology
Breast Neoplasms - genetics
Cancer
Cancer Research
Capillaries
Epidemiology
Female
Hematology
Humans
Lymph nodes
Lymph Nodes - pathology
Lymph Nodes - surgery
Lymphatic Metastasis - genetics
Lymphatic Metastasis - pathology
Lymphatic system
Lymphatic System - pathology
Metastases
Metastasis
Molecular chains
Molecular machines
Oncology
Research Paper
Sentinel Lymph Node - pathology
Sentinel Lymph Node Biopsy
Surgical Oncology
Tumor cells
Tumors
Vascular system
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED90gvgifludUsEnpdAlbZrg0xTHEOaTg72VfBWE2cnaPfjfe-nHpkwFn0roNQ13l9zvuMsdwLVgyjCDyI2FlgaRUDLgROK-ohk36B5oVbXpHD2z4Th6msST5h530Wa7tyHJ6qT-ctkNoS26vjiRcB05NmErdq47KvGY9FeXIZP6-CWMBCEXvA1l_jTFd2O0hjDXoqOV0RnswW6DFv1-Ld592LD5AWyPmnj4Idzdu5zy0tdOdnP_zZY4ksVr4Tf9d_Bp_ekHimwWtEmnfl29-QjGg8eXh2HQtEMINE1IGVAlLKKrntQiUzTToWGh5ByH0kSKZ5mKekKxMAutEdxyYgzCK0N6maSIIzJ6DJ18lttT8DUxNGIMzZZN0D9Gm42m3sSaxtqgdBIPwpYvqW5qhbuWFdN0VeXYsTJFVqaOlWnPg5vlJ-91oYy_iLsts9NmzxQpcbbRLQRfXy1fo7a7EIbM7WxR0biW6EjnwUktpOXfiEgE43HkwW0rtdXkvy7l7F_U57BDnPpUGYBd6JTzhb1AVFKqy0oLPwGABtZ4
  priority: 102
  providerName: Springer Nature
Title Breast cancer metastasis through the lympho-vascular system
URI https://link.springer.com/article/10.1007/s10585-018-9902-1
https://www.ncbi.nlm.nih.gov/pubmed/29796854
https://www.proquest.com/docview/2042950211
https://www.proquest.com/docview/2045269295
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB58gHgR39YXFTwphTZp0wQPssquoigiLqyn0jwKwrpVtx78907adBdZ3EtD2rQNM0nmm8xkBuBUMKmZRuTGQkODWMg84CTHeUULrlE9ULJO0_nwyG778d0gGbgNt7Fzq2zXxHqh1qWye-SopOPKmaBEii4_PgObNcpaV10KjUVYtqHLrEtXOkin5yLTZiUmjAQhF7y1ajZH5xAooyKN3RI2v8dfuTQDNmcMpbX86a3DmgOOfqfh9AYsmNEmrDw40_gWXFxZ9_LKV5aNX_67qbCWj9_GvkvFg6Xxhz_IvTJo_U_9JpDzNvR73Zfr28BlRggUTUkVUCkMAq0oV6KQtFChZmHOOVZzHUteFDKOhGRhERotuOFEa0RamkRFThFSFHQHlkblyOyBr4imMWMowUyKqjKKb6SxThRNlEZGpR6ELV0y5cKG2-wVw2wa8NiSMkNSZpaUWeTB2eSVjyZmxrzGhy2xMzd9xtmU2R6cTB7jwLfWjHxkyu-6jc2Oju082G2YNPkbEalgPIk9OG-5Nv34v13Zn9-VA1gldrzU3n-HsFR9fZsjRCSVPK6HHV557-YYljs3r_ddLK-6j0_PeLdPOr82od7I
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8QwEB50BfVFvK1nBX1RCm3Spgki4rWux_qk4FttjoKw7qrbRfxT_kYnPXYR0TefSmjahsk3V2cyA7AjmNRMo-XGfEO9UMjU4yRFvqIZ1-geKFm06WzfstZ9ePUQPYzBZ30WxqZV1jKxENS6p-w_cnTSUXJGqJGCo5dXz3aNstHVuoVGCYtr8_GOLlv_8PIM93eXkOb53WnLq7oKeIrGJPeoFAaNlCBVIpM0U75mfso5DlMdSp5lMgyEZH7mGy244URrtFI0CbKUojrOKL53HCZCSoXlKN68GJ3DjEvJTxjxfC54HUUtj-qhYY6OO5JB2H4i3_XgD-P2R2C20HfNWZipDFX3uETWHIyZ7jxMtqtQ_AIcnNh09txVFjZv7rPJcZT2n_pu1foHr8btfCBael6d7-qWhaMX4f5faLYEjW6va1bAVUTTkDHUmCZG1xzNBdxTHSkaKY3AiB3wa7okqipTbrtldJJRgWVLygRJmVhSJoEDe8NHXsoaHX9NXq-JnVTs2k9G4HJge3gbGc1GT9Ku6Q2KObYbO85zYLncpOHXiIgF41HowH69a6OX_7qU1b-XsgVTrbv2TXJzeXu9BtPEYqfIPFyHRv42MBtoDeVys4CgC4__jfkvCIgYZA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8QwEB48QHwRb-tZQV-UYpu0aYKIeC3e-KCwb7W5QNBddSviX_PXOemxi4i--VRC0zbMfJOZ6UxmADYEk5pptNxYaGgQC5kHnOQoV9Ryje6BkmWbzqtrdnoXn7eT9hB8NmdhXFplsyeWG7XuKvePHJ103DkT1EjRjq3TIm6OW_vPL4HrIOUirU07jQoiF-bjHd233t7ZMfJ6k5DWye3RaVB3GAgUTUkRUCkMGixRroSV1KpQszDnHIe5jiW3VsaRkCy0odGCG060RotFk8jmFFWzpfjeYRhNaRI5GUvb6eBMZlppAcJIEHLBm4hqdWwPjXR04pEkwvUW-a4Tfxi6P4K0pe5rTcJEbbT6BxXKpmDIdKZh7KoOy8_A7qFLbS985SD06j-ZAkd576Hn122A8Gr8xw9ETjdocl_9qoj0LNz9C83mYKTT7ZgF8BXRNGYMtadJ0U1H0wH5qxNFE6URJKkHYUOXTNUly13njMdsUGzZkTJDUmaOlFnkwVb_keeqXsdfk5cbYme16PayAdA8WO_fRqFzkZS8Y7pv5RzXmR3neTBfMan_NSJSwXgSe7DdcG3w8l-Xsvj3UtZgDNGeXZ5dXyzBOHHQKZMQl2GkeH0zK2gYFXK1RKAP9_8N-S8AmRyR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+cancer+metastasis+through+the+lympho-vascular+system&rft.jtitle=Clinical+%26+experimental+metastasis&rft.au=Nathanson%2C+S+David&rft.au=Krag%2C+David&rft.au=Kuerer%2C+Henry+M&rft.au=Newman%2C+Lisa+A&rft.date=2018-08-01&rft.issn=1573-7276&rft.eissn=1573-7276&rft.volume=35&rft.issue=5-6&rft.spage=443&rft_id=info:doi/10.1007%2Fs10585-018-9902-1&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0262-0898&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0262-0898&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0262-0898&client=summon